Skip to main content
editorial
. 2018 Nov 15;4(Suppl 2):9–15. doi: 10.1016/S2055-6640(20)30348-4

Table 1.

Analysis of data from IeDEA to inform progress on 90-90-90 targets

90-90-90 target Analyses performed Data sources
First 90: 90% of all people living with HIV know their status No data available in IeDEA None
Second 90: 90% of people diagnosed with HIV are on sustained ART Analyses of CD4 cell counts at the start of ART [29–31] All seven IeDEA regions, ART-CC, COHERE, NISDI, PHACS and IMPACCT
Analysis of delays from enrolment in HIV care to ART initiation and the influence and impact of ART guideline changes among adults and children [32,33] All seven IeDEA regions
Analysis of retention in care, mortality and loss to follow-up among HIV-infected children and adults on ART [34] All seven IeDEA regions
Third 90: 90% of all people receiving ART are virally suppressed Analysis of routine viral load data to assess viral suppression among adults and children within the first 3 years after initiating ART [35] All seven IeDEA regions

ART: antiretroviral therapy; ART-CC: ART Cohort Collaboration; COHERE: Collaboration of Observational HIV Epidemiological Research Europe in EuroCoord; IMPAACT: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; NISDI: NICHD Site Development Initiative; PHACS: Pediatric HIV/AIDS Cohort Study.